Antibody Engineering & Therapeutics Europe Virtual 2021: The Rewind - Antibody Engineering & Therapeutics Europe 2021: The Rewind (Gate)

Antibody Engineering & Therapeutics Europe Virtual 2021: The RewindA Post-event ReportWe take a look back at highlights from the week, including summaries of the top keynotes and popular presentations.Contents

Introduction & Contents

Revisiting Top Presentations

Tackling COVID-19 with Human Neutralizing Antibodies

Presentation Summary: An Adaptable Antibody-based Platform for Flexible Synthetic Peptide-based Cargo Delivery Based on Agonistic CD40-directed Antibodies

Anti-CD38/CD28xCD3 Trispecific T cell Engager for the Treatment of Multiple Myeloma

Case Study: Amplifying Antibody Diversity

Live Keynote Highlights

Sugar Switches of IgG in Human Immune Responses Affect the Outcome of COVID-19

Mechanisms of Antibody-mediated Resistance to Infectious Diseases

Advances in Bispecific, Soluble TCR Therapies

Amplifying Antibody Diversity: Single-Cell Screening Combined with Repertoire Sequencing from Humanized Mice

See you again at Antibody Engineering & Therapeutics - Delivered as a Hybrid Event from December 12 - 16, 2021